What does CUSIP 74168J101 represent in this 13F holders report?

CUSIP 74168J101 is the security identifier for PRME - Prime Medicine, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held PRME - Prime Medicine, Inc. - COMMON STOCK in Q2 2023?

77 institutional investors reported PRME - Prime Medicine, Inc. - COMMON STOCK for Q2 2023. Use the holders table for investor-level position and value details.

Prime Medicine, Inc. - COMMON STOCK (PRME)

CUSIP: 74168J101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / COMMON STOCK
Shares outstanding: 181,672,212
Total 13F shares: 46,131,758
Share change: +4,393,183
Total reported value: $675,732,293
Price per share: $14.65
Number of holders: 77
Value change: +$67,078,075
Number of buys: 53
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 74168J101?
CUSIP 74168J101 identifies PRME - Prime Medicine, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 74168J101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GV 2019 GP, L.L.C.	3/4/5	10%+ Owner	— class O/S missing	11,862,498	$177,594,643	—	20 Jun 2023	3/4/5
Alphabet Inc.	13F	Company	7.3%	13,284,688	$163,401,662	—	31 Mar 2023	13F
FMR LLC	3/4/5 13F	Other* · Company	4.7% from 13F	8,462,946	$126,699,612	—	24 Oct 2022	3/4/5 13F
Redmile Group, LLC	13F	Company	1.1%	1,992,843	$24,511,969	—	31 Mar 2023	13F
ARK Investment Management LLC	13F	Company	1.1%	1,922,277	$23,644,007	—	31 Mar 2023	13F
MWG Management Ltd.	13F	Company	1%	1,835,876	$22,581,275	—	31 Mar 2023	13F
FIL Ltd	13F	Company	0.99%	1,805,558	$22,208,363	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.83%	1,514,123	$18,623,714	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	0.57%	1,028,466	$12,650,132	—	31 Mar 2023	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.55%	997,572	$12,270,136	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.5%	903,741	$11,117,000	—	31 Mar 2023	13F
Amova Asset Management Americas, Inc.	13F	Company	0.55%	999,333	$10,992,663	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.49%	885,314	$10,889,362	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.49%	884,446	$10,878,686	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	0.4%	734,350	$9,033,000	—	31 Mar 2023	13F
Casdin Capital, LLC	13F	Company	0.4%	734,350	$9,032,505	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	0.33%	600,000	$7,380,000	—	31 Mar 2023	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.28%	500,000	$6,150,000	—	31 Mar 2023	13F
Samsara BioCapital, LLC	13F	Company	0.26%	470,304	$5,784,739	—	31 Mar 2023	13F
Greenwich Wealth Management LLC	13F	Company	0.19%	349,000	$4,293,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	240,345	$2,956,243	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.1%	189,428	$2,329,964	—	31 Mar 2023	13F
WEXFORD CAPITAL LP	13F	Company	0.08%	153,705	$1,890,572	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	150,267	$1,848,284	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.08%	150,000	$1,845,000	—	31 Mar 2023	13F
OUP Management Co., LLC	13F	Company	0.07%	121,255	$1,491,437	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.05%	90,079	$1,107,971	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	73,427	$903,152	—	31 Mar 2023	13F
Laurion Capital Management LP	13F	Company	0.03%	60,000	$738,000	—	31 Mar 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.03%	45,631	$561,261	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.02%	41,900	$515,370	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.02%	33,385	$410,636	—	31 Mar 2023	13F
BRANDYWINE MANAGERS, LLC	13F	Company	0.02%	32,977	$405,617	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.02%	32,500	$399,750	—	31 Mar 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.02%	32,197	$396,023	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.02%	30,068	$369,837	—	31 Mar 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	23,922	$294,241	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	20,967	$257,894	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	19,663	$241,855	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	17,999	$221,388	—	31 Mar 2023	13F
Clarius Group, LLC	13F	Company	0.01%	16,080	$197,784	—	31 Mar 2023	13F
OPPENHEIMER & CO INC	13F	Company	0.01%	15,118	$185,951	—	31 Mar 2023	13F
RED LIGHTHOUSE INVESTMENT MANAGEMENT, LLC	13F	Company	0.01%	14,950	$183,885	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.01%	14,705	$180,872	—	31 Mar 2023	13F
CAPSTONE INVESTMENT ADVISORS, LLC	13F	Company	0.01%	14,551	$178,977	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.01%	14,128	$174,000	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.01%	14,091	$173,111	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	12,897	$159,000	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	10,860	$133,579	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	10,759	$132,000	—	31 Mar 2023	13F

Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q2 2023

As of 30 Jun 2023, Prime Medicine, Inc. - COMMON STOCK (PRME) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,131,758 shares. The largest 10 holders included Alphabet Inc., FMR LLC, VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., BlackRock Inc., ARK Investment Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, FIL Ltd, and MWG Management Ltd.. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.